Cargando…
Exome Sequencing of Cell-Free DNA from Metastatic Cancer Patients Identifies Clinically Actionable Mutations Distinct from Primary Disease
The identification of the molecular drivers of cancer by sequencing is the backbone of precision medicine and the basis of personalized therapy; however, biopsies of primary tumors provide only a snapshot of the evolution of the disease and may miss potential therapeutic targets, especially in the m...
Autores principales: | Butler, Timothy M., Johnson-Camacho, Katherine, Peto, Myron, Wang, Nicholas J., Macey, Tara A., Korkola, James E., Koppie, Theresa M., Corless, Christopher L., Gray, Joe W., Spellman, Paul T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552879/ https://www.ncbi.nlm.nih.gov/pubmed/26317216 http://dx.doi.org/10.1371/journal.pone.0136407 |
Ejemplares similares
-
Circulating tumor DNA dynamics using patient-customized assays are associated with outcome in neoadjuvantly treated breast cancer
por: Butler, Timothy M., et al.
Publicado: (2019) -
Urinary Comprehensive Genomic Profiling Correlates Urothelial Carcinoma Mutations with Clinical Risk and Efficacy of Intervention
por: Bicocca, Vincent T., et al.
Publicado: (2022) -
Proliferative polyploid cells give rise to tumors via ploidy reduction
por: Matsumoto, Tomonori, et al.
Publicado: (2021) -
Targeting mitochondria in cancer therapy could provide a basis for the selective anti-cancer activity
por: Rozanov, Dmitri, et al.
Publicado: (2019) -
Expanding the Diversity of Imaging-Based RNAi Screen Applications Using Cell Spot Microarrays
por: Rantala, Juha K., et al.
Publicado: (2013)